Advanced search
Publication Cover
Current Medical Research and Opinion Volume 38, 2022 - Issue 8
Submit an article Journal homepage
2,300
Views
3
CrossRef citations to date
0
Altmetric
Respiratory Medicine

Understanding physician’s knowledge and perception of chronic cough in Switzerland

Jörg D. Leuppia Cantonal Hospital Baselland, University Clinic of Medicine and Medical Faculty University of Basel, Basel, SwitzerlandCorrespondence[email protected]
,
Patrik Guggisbergb MSD Merck Sharp & Dohme AG, Lucerne, Switzerland
,
Daniel Kochb MSD Merck Sharp & Dohme AG, Lucerne, Switzerland
,
Andrea Favre-Bulleb MSD Merck Sharp & Dohme AG, Lucerne, Switzerland
,
Matteo Fabianic IPSOS Mori Healthcare (Market Access), London, UK
,
Sabina Heinzc IPSOS Mori Healthcare (Market Access), London, UK
&
Andreas Zellerd Centre for Primary Health Care, Medical Faculty, University of Basel, Basel, Switzerland
 show all
Pages 1459-1466 | Received 10 Feb 2022, Accepted 21 Mar 2022, Published online: 15 Apr 2022

References

  • Mahashur A. Chronic dry cough: diagnostic and management approaches. Lung India. 2015;32(1):44–49.
  • Song WJ, Chang YS, Faruqi S, et al. The global epidemiology of chronic cough in adults: a systematic review and Meta-analysis. Eur Respir J. 2015;45(5):1479–1481.
  • Zemp E, Elsasser S, Schindler C, et al. Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA study). The SAPALDIA TeamAm J Respir Crit Care Med. 1999;159(4 Pt 1):1257–1266.
  • Morice AH, Millqvist E, Bieksiene K, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55(1):1901136.
  • Kaplan AG. Chronic cough in adults: make the diagnosis and make a difference. Pulm Ther. 2019;5(1):11–21.
  • Mello CJ, Irwin RS, Curley FJ. Predictive values of the character, timing, and complications of chronic cough in diagnosing its cause. Arch Intern Med. 1996;156(9):997–1003.
  • McGarvey L, Gibson PG. What is chronic cough? Terminology. J Allergy Clin Immunol Pract. 2019;7(6):1711–1714.
  • Iyer VN, Lim KG. Chronic cough: an update. Mayo Clin Proc. 2013;88(10):1115–1126.
  • Chamberlain SA, Garrod R, Douiri A, et al. The impact of chronic cough: a cross-sectional European survey. Lung. 2015;193(3):401–408.
  • McGarvey LP, Birring SS, Morice AH, et al. Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials. The Lancet. 2022;399(10328):909–923.
  • Slovarp L, Loomis BK, Glaspey A. Assessing referral and practice patterns of patients with chronic cough referred for behavioral cough suppression therapy. Chron Respir Dis. 2018;15(3):296–305.
  • QualiPro. 2020; [cited 2021 March]. Available from: https://qualipro.ch/index.html.
  • FMH Ärztestatistik, 2020. https://www.fmh.ch/themen/aerztestatistik/fmh-aerztestatistik.cfm.
  • GOLD/GINA, Diagnosis of diseases of chronic airflow limitation: Asthma, COPD and Asthma-COPD overlap syndrome (ACOS), 2015.Available from: https://goldcopd.org/wp-content/uploads/2016/04/GOLD_ACOS_2015.pdf.
  • Dominguez-Ortega J, Molina París J, Trigueros JA, et al. Use of clinical guidelines and protocols for the management of chronic cough by Spanish physicians and its influence on the diagnosis of chronic cough. Allergy. 2021;76(Suppl. 110):583–637 ABSTRACT 691.
  • Morice AH, Millqvist E, Belvisi MG, et al. Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J. 2014;44(5):1132–1148.
  • Maestu P, et al. A survey of physicians’ perception of the use and effectiveness of diagnostic and therapeutic procedures in chronic cough patients. Lung. 2021; 199:507–515.
  • Sadeghi MH, Wright CE, Hart S, et al. Phenotyping patients with chronic cough: evaluating the ability to predict the response to anti-inflammatory therapy. Ann Allergy Asthma Immunol. 2018;120(3):285–291.
  • Morice A, Dicpinigaitis P, McGarvey L, et al. Chronic cough: new insights and future prospects. Eur Respir Rev. 2021;30(162):210127.
  • Smith JA, McGarvey LPA, Badri H, et al. Effects of a novel sodium channel blocker, GSK2339345, in patients with refractory chronic cough. Int J Clin Pharmacol Ther. 2017;55(9):712–719.
  • Belvisi MG, Birrell MA, Wortley MA, et al. XEN-D0501, a novel transient receptor potential vanilloid 1 antagonist, does not reduce cough in patients with refractory cough. Am J Respir Crit Care Med. 2017;196(10):1255–1263.
  • Muccino D, Green S. Update on the clinical development of gefapixant, a P2X3 receptor antagonist for the treatment of refractory chronic cough. Pulm Pharmacol Ther. 2019;56:75–78.
  • Arinze J, de Roos E, Karimi L, et al. Prevalence and incidence of, and risk factors for chronic cough in the adult population: the Rotterdam study. ERJ Open Res. 2020;6(2):00300–2019.
  • Abozid H, Baxter CA, Hartl S, et al. Distribution of chronic cough phenotypes in the general population: a cross-sectional analysis of the LEAD cohort in Austria. Respir Med. 2022;192:106726.
  • Satia I, Mayhew AJ, Sohel N, et al. Prevalence, incidence and characteristics of chronic cough among adults from the Canadian longitudinal study on aging. ERJ Open Res. 2021;7(2):00160-2021.
  • Swiss Confederation, 2013. Federal law concerning the research of human beings (Human Law LRUm – RU 2013 3215); [cited 2021 May 20]. Available from: https://www.admin.ch/opc/de/official-compilation/2013/3215.pdf.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.